Antituberculosis drugs and hepatotoxicity

被引：54

作者：

Sharma, S. K. ^{[1
]}

机构：

[1] All India Inst Med Sci, Dept Med, Div Pulm & Crit Care Med, New Delhi 110029, India

来源：

INFECTION GENETICS AND EVOLUTION | 2004年 / 4卷 / 02期

关键词：

D O I：

10.1016/j.meegid.2003.01.001

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：167 / 170

页数：4

共 44 条

[1]

[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603

[2] HEPATOTOXICITY CAUSED BY THE COMBINED ACTION OF ISONIAZID AND RIFAMPICIN [J].

ASKGAARD, DS ;

WILCKE, T ;

DOSSING, M .

THORAX, 1995, 50 (02) :213-214

[3]

BLACK M, 1975, GASTROENTEROLOGY, V69, P289

[4] PLASMA HYDRAZINE CONCENTRATIONS IN MAN AFTER ISONIAZID AND HYDRALAZINE ADMINISTRATION [J].

BLAIR, IA ;

TINOCO, RM ;

BRODIE, MJ ;

CLARE, RA ;

DOLLERY, CT ;

TIMBRELL, JA ;

BEEVER, IA .

HUMAN TOXICOLOGY, 1985, 4 (02) :195-202

[5] Treatment, tuberculosis, and human leukocyte antigen [J].

Bothamley, GH .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (07) :907-908

[6]

Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P735

[7]

Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221

[8] Liver injury during antituberculosis treatment: An 11-year study [J].

Dossing, M ;

Wilcke, JTR ;

Askgaard, DS ;

Nybo, B .

TUBERCLE AND LUNG DISEASE, 1996, 77 (04) :335-340

[9] PHARMACOKINETICS OF ISONIAZID METABOLISM IN MAN [J].

ELLARD, GA ;

GAMMON, PT .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (02) :83-113

[10]

ELLARD GA, 1978, AM REV RESPIR DIS, V118, P628

← 1 2 3 4 5 →